Patient case study (fictional) for BSN students nearing graduation

Patient ID: MRN 000123456 (fictional) Name: Thomas Riley (Mr. Riley) Age: 68 Sex: Male DOB: 08/14/1957 Date of admission: 02/07/2026 Admission source: ED from home via EMS Code status: Full Code Allergies: Penicillin (rash)

Presenting complaint: Progressive shortness of breath for 3 days, increased lower-extremity swelling, cough with white sputum, orthopnea (needs 3 pillows), decreased exercise tolerance.

Past medical history:

  • Chronic heart failure with reduced ejection fraction (HFrEF), diagnosed 5 years ago (EF 30%)
  • Coronary artery disease (stented 3 years ago)
  • Hypertension
  • Chronic obstructive pulmonary disease (COPD), emphysema-predominant
  • Type 2 diabetes mellitus, diet-controlled
  • Chronic kidney disease stage 3a (eGFR ~52 mL/min/1.73 m2)
  • Hyperlipidemia
  • Osteoarthritis of knees

Surgical history:

  • CABG x1 (no), PCI with stent 3 years ago
  • Left knee arthroscopy

Social history:

  • Lives with wife in single-level home
  • Retired factory worker
  • Former smoker: 40 pack-year history, quit 5 years ago
  • Alcohol: occasional wine
  • No illicit drug use
  • Support: spouse able to assist; adult daughter nearby

Home medications (prior to admission):

  • Metoprolol succinate 100 mg PO daily
  • Lisinopril 20 mg PO daily
  • Furosemide 40 mg PO daily (often misses doses)
  • Spironolactone 25 mg PO daily
  • Atorvastatin 40 mg PO nightly
  • Tiotropium inhaler 18 mcg daily
  • Albuterol inhaler PRN (uses 23 times/day)
  • Aspirin 81 mg PO daily
  • Multivitamin

Allergies: Penicillin rash

Initial ED assessment / triage vitals:

  • T: 99.1F (37.3C)
  • HR: 110 bpm, regular
  • BP: 160/92 mmHg
  • RR: 26 breaths/min
  • SpO2: 88% on room air, improves to 94% on 4 L/min nasal cannula
  • Pain: 2/10 (chest tightness occasionally)

Physical exam (on admission):

  • General: Alert, anxious, mild respiratory distress
  • HEENT: No JVD at 30 degrees (note: JVD present when more upright)
  • Lungs: Bilateral crackles at bases, decreased breath sounds with expiratory wheeze; mild use of accessory muscles
  • Cardiac: Tachycardic, S1/S2, S3 present, no murmurs noted
  • Abdomen: Soft, non-tender
  • Extremities: Bilateral pitting edema to mid-shins, cool peripheries
  • Neuro: Alert and oriented x3

Initial diagnostics:

  • CXR: Cardiomegaly with pulmonary vascular congestion and bilateral interstitial/alveolar edema, small bilateral pleural effusions
  • ECG: Sinus tachycardia, no acute ischemic changes
  • BNP: 1,200 pg/mL (elevated)
  • Troponin I: 0.02 ng/mL (normal)
  • ABG on 4 L NC: pH 7.45, PaCO2 34 mmHg, PaO2 70 mmHg (mild hypoxemia)
  • CBC: WBC 9.8 x10^9/L, Hgb 13.2 g/dL, Hct 39%, Plt 210 x10^9/L
  • BMP: Na 132 mmol/L, K 4.8 mmol/L, Cl 98 mmol/L, HCO3 22 mmol/L, BUN 28 mg/dL, Creatinine 1.4 mg/dL (baseline 1.2), Glucose 150 mg/dL
  • LFTs: within normal limits
  • Echo (prior record): EF 30% (last year)
  • Urinalysis: trace protein, otherwise unremarkable
  • Sputum culture: sent (pending)

ED course and admitting diagnosis:

  • Primary: Acute decompensated heart failure (HFrEF exacerbation), likely precipitated by missed diuretic doses and possible COPD exacerbation
  • Secondary: COPD exacerbation, volume overload
  • ED treatment: Supplemental oxygen, IV loop diuretic (furosemide 40 mg IV bolus), nebulized albuterol/ipratropium, started on scheduled IV furosemide infusion protocol pending response, placed on telemetry, continuous pulse oximetry.
  • Admitted to telemetry/medical-surgical step-down unit under cardiology.

Hospital day 1 plan & orders (sample):

  • Continue oxygen titrated to SpO2 92%
  • Furosemide IV 40 mg bolus then 10 mg/hr infusion (adjust per urine output and daily weights)
  • Metoprolol hold until euvolemic and HR <100; resume later per cardiology
  • Continue lisinopril 20 mg PO daily (hold if creatinine rises >30% or K >5.5)
  • Spironolactone hold while on IV diuresis
  • Nebulized albuterol/ipratropium q6h PRN for wheeze
  • VTE prophylaxis: sequential compression devices (consider LMWH once stable)
  • Daily labs: BMP, BNP qAM
  • Strict I&O, daily weight each AM
  • Cardiology consult for HF management and medication titration
  • Respiratory therapy for inhaler technique, nebulizer treatments, pulmonary toilet
  • Diet: cardiac (2 g sodium), diabetic-consistent as needed
  • Education: low-sodium diet, medication adherence, activity tolerance, when to call provider
  • Discharge planning: assess home support, f/up with cardiology & primary care within 1 week, consider home health if needed

Nursing assessment data (ongoing):

  • Urine output: first 6 hours after IV furosemide bolus: 800 mL; next 12 hours: 1,200 mL
  • Weight: admission 95 kg; prior baseline 90 kg (weight gain 5 kg)
  • Vitals (12 hours after admission): T 98.6F, HR 96, BP 138/84, RR 20, SpO2 93% on 2 L NC
  • Breath sounds: crackles improved slightly; dyspnea decreased from moderate to mild
  • Peripheral edema decreased to ankles (pitting 1+)
  • Blood glucose: 160 mg/dL fasting
  • BMP (12 hours): Na 130, K 4.6, Creatinine 1.45 mg/dL, BUN 30

Potential and actual nursing diagnoses (examples):

  • Impaired gas exchange related to pulmonary edema and COPD exacerbation as evidenced by SpO2 88% on room air and bilateral crackles.
  • Excess fluid volume related to compromised regulatory mechanism (heart failure) as evidenced by weight gain, peripheral edema, pulmonary congestion, BNP elevated.
  • Activity intolerance related to decreased cardiac output as evidenced by dyspnea on exertion and tachycardia with minimal activity.
  • Risk for electrolyte imbalance related to diuretic therapy as evidenced by diuretic orders and borderline creatinine/BUN elevation.
  • Deficient knowledge regarding disease process and medication adherence related to missed diuretic doses.

Nursing care plan interventions (examples with rationale and expected outcomes):

  1. Oxygen therapy and respiratory support
  • Intervention: Administer O2 to maintain SpO2 92%; monitor respiratory rate, work of breathing, ABGs.
  • Rationale: Improve oxygenation, decrease work of breathing.
  • Expected outcome: SpO2 92%, RR <22, decreased dyspnea.
  1. Fluid removal and monitoring
  • Intervention: Administer IV furosemide per order; monitor urine output hourly during infusion, record daily weights, assess mucous membranes and skin turgor, monitor electrolytes and renal function qAM.
  • Rationale: Reduce volume overload, prevent renal impairment and electrolyte disturbances.
  • Expected outcome: 0.51.0 kg weight loss/day initially, decreased edema, stable creatinine.
  1. Prevention of complications
  • Intervention: Telemetry monitoring for arrhythmias, fall risk precautions, VTE prophylaxis.
  • Rationale: HF patients at risk for arrhythmias, falls, and thromboembolism.
  • Expected outcome: No arrhythmias requiring emergent intervention, no falls, no DVT.
  1. Medication management and reconciliation
  • Intervention: Reconcile meds, clarify home diuretic adherence, educate on medication purposes and schedule, coordinate with pharmacy for discharge meds (ensure diuretic dosing and potassium monitoring).
  • Rationale: Prevent readmission due to nonadherence and optimize HF regimen.
  • Expected outcome: Patient verbalizes meds and doses, demonstrates inhaler technique.
  1. Education and discharge planning
  • Intervention: Teach low-sodium diet, daily weights, recognition of worsening HF signs (increased SOB, >23 lb overnight gain), when to seek care; arrange follow-up appointments; involve spouse in teaching.
  • Rationale: Early recognition prevents readmission; caregiver involvement improves adherence.
  • Expected outcome: Patient and spouse demonstrate understanding and plan for outpatient follow-up.
  1. Mobility and activity progression
  • Intervention: Encourage graded activity as tolerated, monitor vitals with ambulation, provide rest periods.
  • Rationale: Prevent deconditioning while avoiding cardiac stress.
  • Expected outcome: Activity tolerance improves, HR and BP within acceptable range during activity.

Progress notes example (Hospital day 2 morning):

  • Subjective: Denies chest pain; reports breathing easier, requires 2 pillows at night now. States will try to take furosemide at home but sometimes forgets.
  • Objective: Vitals stable, SpO2 94% on 2 L NC, RR 18, HR 86, BP 130/78. Lungs: decreased crackles. Urine output last 24 hrs: 2,400 mL. Weight 92 kg (down 3 kg from admission). BMP: Na 131, K 4.4, Creatinine 1.35 mg/dL.
  • Assessment: Responding to diuresis; stable for step-down care. Needs med teaching and discharge planning.
  • Plan: Continue diuretic per protocol, hold spironolactone until assessment by cardiology, schedule cardiology follow-up, begin discharge teaching, consider home diuretic supply and home health for initial medication reconciliation and weight monitoring.

Lab trends to monitor:

  • Daily BMP (Na, K, Cr, BUN)
  • BNP trends
  • Weight and I&O
  • Oxygenation and ABGs if indicated
  • ECG/Telemetry for arrhythmias
  • Sputum culture results (if infectious etiology suspected)

Discharge considerations (anticipated if stable by day 34):

  • Transition IV diuretics to oral high-dose furosemide (e.g., 80 mg PO daily or as individualized) with clear instructions and pharmacy reconciliation
  • Reinstate guideline-directed medical therapy (beta-blocker, ACE inhibitor) with cardiology input; titration outpatient
  • Arrange cardiology appointment in 37 days
  • Provide written and teach-back education: low-sodium diet, daily weights, medication schedule, inhaler technique, signs/symptoms requiring immediate care
  • Consider home health for weight, vitals, medication reconciliation for first 12 weeks
  • Provide referral to CHF clinic or heart failure management program

Student tasks / learning activities (for evaluation):

  1. Perform focused cardiopulmonary assessment and document findings.
  2. Calculate fluid balance for prior 24 hours and interpret significance.
  3. Formulate 3 prioritized nursing diagnoses with supporting data.
  4. Create a 24-hour nursing care plan with specific interventions, rationales, and measurable outcomes.
  5. Demonstrate proper inhaler technique and teach-back with spouse.
  6. Identify potential medication interactions/contraindications (e.g., ACE inhibitor + spironolactone with rising creatinine/K).
  7. Develop discharge teaching checklist and complete a teach-back session (document results).
  8. Recognize signs of worsening HF and when to escalate care.
  9. Interpret BMP trend and suggest nursing actions for abnormal K or creatinine changes.
  10. Communicate change-of-shift report including SBAR to receiving nurse.

Attached Files (PDF/DOCX): Clinical Course Level 4 DPCD (2).pdf

Note: Content extraction from these files is restricted, please review them manually.

WRITE MY PAPER


Comments

Leave a Reply